Pharma has its own fear of patients in a world of Web 2.0, with concerns over inappropriate identification of safety signals (FYI, any known adverse experience linked to a specific drug that can be traced to an identifiable patient with an identifiable reporter must be reported to FDA).
Would you like to comment?
Join Diigo for a free account, or sign in if you are already a member.
Would you like to comment?
Join Diigo for a free account, or sign in if you are already a member.